Vir Biotechnology (VIR) FCF Margin (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vir Biotechnology | 1.33 Bn | 1.33 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.78 Mn |
| Dec 31, 2025 | 6.99 Mn |
| Sep 30, 2025 | -5.98 Mn |
| Jun 30, 2025 | -748,167.00 |
| Mar 31, 2025 | -190,577.00 |
| Dec 31, 2024 | 659,700.00 |
| Sep 30, 2024 | -476,808.00 |
| Jun 30, 2024 | -233,806.00 |
| Mar 31, 2024 | 43,686.00 |
| Dec 31, 2023 | 539,352.00 |
| Sep 30, 2023 | 445,491.00 |
| Jun 30, 2023 | -1.03 Mn |
| Mar 31, 2023 | -25,634.00 |
| Dec 31, 2022 | 1,924.00 |
| Sep 30, 2022 | -228,607.00 |
| Jun 30, 2022 | 226,913.00 |
| Mar 31, 2022 | 4,401.00 |
| Dec 31, 2021 | 10,751.00 |
| Sep 30, 2021 | -19,013.00 |
| Jun 30, 2021 | 463,192.00 |
| Mar 31, 2021 | 32,214.00 |
| Dec 31, 2020 | -221,052.00 |
| Sep 30, 2020 | -263,209.00 |
| Jun 30, 2020 | 82,624.00 |
| Mar 31, 2020 | 318,275.00 |
| Dec 31, 2019 | -182,721.00 |
| Sep 30, 2019 | -89,431.00 |
| Jun 30, 2019 | -41,651.00 |
| Mar 31, 2019 | 29,352.00 |